[Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
Bosó-Ribelles
V
V
Servicio de Farmacia, Hospital Universitario La Fe, Valencia, Spain.
Roma-Sánchez
E
E
Salavert-Lletí
M
M
Hernández-Martí
V
V
Poveda-Andrés
J L
JL
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000737:chemistry / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D004311:Double-Blind Method; D024881:Drug Resistance, Bacterial; D006033:Glycylglycine / Q000009:adverse effects / Q000737:chemistry / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008911:Minocycline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D006033:Glycylglycine; D000078304:Tigecycline; D008911:Minocycline